Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
Cypress Pharmaceuticals
|
| gptkbp:acquisition |
Zylera Pharmaceuticals
|
| gptkbp:ceo |
gptkb:John_S._Mc_Gowan
|
| gptkbp:employees |
approximately 100
|
| gptkbp:focus |
pain management
|
| gptkbp:founded |
gptkb:1996
|
| gptkbp:headquarters |
gptkb:The_Woodlands,_Texas
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pernix Therapeutics
|
| gptkbp:partnership |
various healthcare providers
|
| gptkbp:products |
Kadian
Pernix's generic products Trezix Zohydro ER |
| gptkbp:revenue |
$50 million (2020)
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:website |
www.pernixtherapeutics.com
|
| gptkbp:bfsParent |
gptkb:Alvogen
|
| gptkbp:bfsLayer |
4
|